Eleos Health
Series C in 2025
Eleos Health offers automated healthcare technology solutions. Its AI-powered Speech-to-Insights system aids clinicians in making decisions swiftly, ensuring personalized, efficient, and cost-effective patient care.
Beads is a dedicated operator of hospice housing facilities, specializing in providing end-of-life care for patients with terminal cancer or intractable neurological diseases. The company offers a residential setting that combines nursing care and palliative support, aiming to create a comfortable and dignified environment for patients to spend their final days.
Based on our deep science and focused on patients in need.
Spry is a digital health platform that enables movement health professionals to collect and analyze patient data in real time. By leveraging machine learning and artificial intelligence, the platform provides personalized protocols based on evidence-based practices and standards of care. This allows practitioners and owners of physical therapy centers to effectively manage both clinical and administrative functions, enhancing the quality of patient care and operational efficiency.
Fat Fee is a health food supplier, mainly engaged in the healthy upgrading of oils and the development and application of fat replacement technology based on bio-oil refining technology, and has launched a series of edible oil products.
Arnatar Therapeutics
Series A in 2024
Arnatar Therapeutics is a biopharmaceutical company focused on developing novel nucleic acid medications. It specializes in programmable RNA therapeutics for precision therapies targeting liver and extrahepatic metabolic and rare diseases, aiming to restore protein function and provide long-term disease control.
Pelago specializes in virtual substance use management, empowering members to overcome addiction, primarily tobacco, alcohol, or opioids. It offers cognitive behavioral therapy (CBT) and medication-assisted treatment (MAT) programs, delivered via an accessible platform that integrates with health plans and wellness platforms.
HiLabs is a developer of a healthcare data mining platform that aims to enhance data-driven decision-making within healthcare organizations. By leveraging artificial intelligence, HiLabs empowers employees to explore their data intuitively, uncover novel insights, and interact with data visualizations. The platform allows users to customize dashboards and generate new attributes, thus enhancing their ability to understand and utilize client health data effectively. HiLabs recognizes that healthcare providers possess vital domain knowledge but often lack the necessary tools to extract meaningful insights from their data. Through its innovative solutions, HiLabs bridges this gap, enabling healthcare organizations to harness their data more efficiently and improve overall decision-making processes.
EurekaBio
Series B in 2024
EurekaBio specializes in developing solutions for cancer immunotherapy, particularly in the realm of cell therapy. The company offers automated manufacturing equipment for cell therapies and a platform for vector production. By focusing on automation in medical equipment related to gene and cell therapy, EurekaBio aims to enhance the accuracy and efficiency of cancer treatments, ultimately benefiting patients in need of innovative therapeutic options.
MakeO develops an at-home oral and skin care platform that enables customers to achieve their desired smile and complexion. The platform offers at-home solutions for teeth straightening and whitening and for skin rejuvenation, including invisible aligners, laser hair removal, and clinically formulated skincare products.
Everheal
Venture Round in 2024
Everheal is a health technology company focused on supporting women throughout their pregnancy journey, from pre-conception to postpartum. It offers an all-in-one platform for gynecologists to enhance clinical outcomes and generate revenue through patient support features such as nutrition tracking, video consultations, automated vital sign monitoring, and an e-store.
PlasmaGen Biosciences
Venture Round in 2023
PlasmaGen Biosciences Pvt. Ltd., established in 2010 and based in Bengaluru, India, is a biopharmaceutical company specializing in plasma protein therapies. The company manufactures a range of products including PlasmaGlob and AlbuMax, brands of Normal Human Immunoglobulin for Intravenous use, PlasmaRho-D I.V. for Rh immunization suppression, PlasmaRAB for rabies infection prophylaxis, PlasmaHep for hepatitis B exposure, VerBumin for conditions like hypovolemic shock and burns, and Gammafact-VIII. These products cater to various medical fields such as hematology, oncology, immunology, pediatrics, rheumatology, dermatology, and neurology. The company serves clinicians, medical practitioners, corporate hospitals, and government institutions.
Shinobi Therapeutics
Series A in 2023
Shinobi Therapeutics is a biotechnology company dedicated to developing innovative cell therapies that utilize hypoimmune CD8αβ induced pluripotent stem cells (iPS-T cells) to enhance cancer treatment and address other diseases. The company's advanced immune evasion technology aims to improve the effectiveness and accessibility of these therapies, ultimately reducing costs and enhancing patient outcomes. By focusing on durable responses and the potential for redosing, Shinobi Therapeutics strives to provide the healthcare industry with comprehensive immune therapies that can address a range of diseases, including cancer and genetic disorders.
Eleos Health
Series B in 2023
Eleos Health offers automated healthcare technology solutions. Its AI-powered Speech-to-Insights system aids clinicians in making decisions swiftly, ensuring personalized, efficient, and cost-effective patient care.
Sonosemi Medical
Series B in 2023
Sonosemi Medical is a provider of medical devices that specializes in the development of pan-vascular active interventional products, diagnosis, and treatment solutions.
Doceree is a healthcare marketing technology company that provides a platform and solutions to help pharmaceutical and healthcare brands reach healthcare professionals. Its programmatic platform supports physician engagement and targeted advertising across physician networks, medical journals, telemedicine platforms, and relevant digital channels, delivering compliant, scalable messages. The platform uses artificial intelligence, data segmentation, and analytics to identify target healthcare professionals and optimize reach across global digital ecosystems. Doceree serves pharmaceutical brands, medical device brands, consumer health brands, hospitals, and media agencies, enabling access to physician-only environments and enabling compliant engagement at scale.
New Vision Medical
Series A in 2023
New Vision Medical is an IT infrastructure service provider that offers clinical trial-related digital platforms and services.
K36 Therapeutics
Series B in 2023
K36 Therapeutics develops small molecule therapeutics for cancer treatment. It translates epigenetic modulation of oncogenic pathways into small molecule therapies.
NOCD Inc. is a Chicago-based company founded in 2014 that specializes in developing a mobile application aimed at assisting individuals with obsessive-compulsive disorder (OCD). The platform connects users to licensed therapists who specialize in OCD through face-to-face video therapy sessions. Utilizing cognitive behavioral therapy techniques, the application guides users in self-treatment and monitoring of their symptoms, offering tools for exposure and response prevention exercises. In addition to therapy sessions, NOCD provides 24/7 support via self-help resources and peer communities, facilitating ongoing care and enabling patients to manage their condition effectively. The company focuses on improving treatment outcomes for OCD through its innovative online platform.
Enzene Biosciences
Venture Round in 2023
Enzene Biosciences develops cost-effective biosimilars through advanced analytics and state-of-the-art manufacturing. It aims to provide affordable medicines swiftly, utilizing good manufacturing practices (GMP) processes.
RedPine Medical
Series C in 2022
RedPine Medical, founded in 2015 and headquartered in Guangzhou, China, specializes in the manufacture of single-use medical endoscopes. The company focuses on providing advanced minimally invasive surgical devices for various applications, including urology, gynecology, ear, nose, and throat (ENT), pneumology, gastroenterology, and general surgeries. By emphasizing innovative solutions, RedPine aims to enhance detection, diagnosis, and treatment in medical settings, positioning itself as a global leader in the field of integrated minimally invasive surgical solutions.
ABK Biomedical
Series C in 2022
Founded in 2012, ABK Biomedical specializes in developing embolotherapeutic products for treating hypervascular tumors. Its primary focus is improving treatment options for patients through innovative microsphere technology.
Elucidata
Series A in 2022
Elucidata Corporation, established in 2015 and based in New Delhi, India, specializes in accelerating drug discovery by translating phenotypic screenings into therapeutic strategies. The company's core offering is Polly, a proprietary SaaS platform that transforms drug discovery through curated biomedical molecular data. Polly hosts over 230,000 multi-omic datasets, with around 50,000 new datasets added monthly, and offers exclusive access to curated data ready for machine learning workflows. This platform enables 10x faster identification of therapeutic assets and has facilitated the detection of multiple validated drug targets across immunology, oncology, and metabolomic disorders. Polly supports discovery programs at prominent biopharma companies such as Pfizer, Agios Pharmaceuticals, Genentech, and Yale, with over 35 research partners from premier institutions.
Spry is a digital health platform that enables movement health professionals to collect and analyze patient data in real time. By leveraging machine learning and artificial intelligence, the platform provides personalized protocols based on evidence-based practices and standards of care. This allows practitioners and owners of physical therapy centers to effectively manage both clinical and administrative functions, enhancing the quality of patient care and operational efficiency.
Immuneel Therapeutics
Series A in 2022
Immuneel Therapeutics specializes in developing innovative cell and gene therapies for cancer treatment. The company focuses on CAR-T cell therapies, which are created by extracting blood cells from patients and genetically engineering healthy immune cells to specifically target malignant cells. This approach allows cancer patients to benefit from advanced cell-based immunotherapies that have the potential to transform their treatment outcomes.
EurekaBio
Series B in 2022
EurekaBio specializes in developing solutions for cancer immunotherapy, particularly in the realm of cell therapy. The company offers automated manufacturing equipment for cell therapies and a platform for vector production. By focusing on automation in medical equipment related to gene and cell therapy, EurekaBio aims to enhance the accuracy and efficiency of cancer treatments, ultimately benefiting patients in need of innovative therapeutic options.
Proximie is a health technology company that enables surgeons worldwide to collaborate remotely using augmented reality, artificial intelligence, and machine learning. Its platform allows surgeons to visually guide complex surgeries, democratizing access to advanced surgical knowledge.
Doceree is a healthcare marketing technology company that provides a platform and solutions to help pharmaceutical and healthcare brands reach healthcare professionals. Its programmatic platform supports physician engagement and targeted advertising across physician networks, medical journals, telemedicine platforms, and relevant digital channels, delivering compliant, scalable messages. The platform uses artificial intelligence, data segmentation, and analytics to identify target healthcare professionals and optimize reach across global digital ecosystems. Doceree serves pharmaceutical brands, medical device brands, consumer health brands, hospitals, and media agencies, enabling access to physician-only environments and enabling compliant engagement at scale.
Eleos Health
Series A in 2022
Eleos Health offers automated healthcare technology solutions. Its AI-powered Speech-to-Insights system aids clinicians in making decisions swiftly, ensuring personalized, efficient, and cost-effective patient care.
ekincare is an AI-powered integrated health benefits platform that provides personalized healthcare solutions for organizations and employees. It offers a range of services including online consultations, health check-ups, medicine delivery, wellness programs, and fitness services.
TreeENT Health is a specialized healthcare provider focused on ear, nose, and throat (ENT) services, established in 2017 and headquartered in Hangzhou, China. The company operates a chain of medical centers that cater to a variety of ENT conditions, including suppurative otitis media, allergic rhinitis, chronic sinusitis, and thyroid cancer. TreeENT Health utilizes advanced medical technologies, such as minimally invasive surgical techniques, internet-enabled services, and wearable medical devices, to enhance patient care. Their offerings include diagnostic services like Danish ear hearing detection, nasal endoscopy video examinations, and nasopharyngoscopy, along with personalized chronic disease rehabilitation. The integration of online appointment scheduling through platforms like WeChat facilitates convenient access to expert consultations and treatments, ensuring a high-quality experience for patients.
Ujala Cygnus Healthcare Services
Venture Round in 2022
Ujala Cygnus Healthcare Services is a New Delhi-based operator of a chain of low-budget super-specialty hospitals focused on delivering quality healthcare to Tier 2 and Tier 3 communities in India. The organization provides a range of medical services, including both emergency and elective procedures, with expertise in various surgical specialties such as joint replacement, trauma surgery, neurological and spine surgery, urology, ophthalmology, and fertility. By offering advanced medical options at an affordable cost, Ujala Cygnus aims to enhance healthcare accessibility and address the needs of underserved populations in these regions.
K36 Therapeutics
Series A in 2021
K36 Therapeutics develops small molecule therapeutics for cancer treatment. It translates epigenetic modulation of oncogenic pathways into small molecule therapies.
NOCD Inc. is a Chicago-based company founded in 2014 that specializes in developing a mobile application aimed at assisting individuals with obsessive-compulsive disorder (OCD). The platform connects users to licensed therapists who specialize in OCD through face-to-face video therapy sessions. Utilizing cognitive behavioral therapy techniques, the application guides users in self-treatment and monitoring of their symptoms, offering tools for exposure and response prevention exercises. In addition to therapy sessions, NOCD provides 24/7 support via self-help resources and peer communities, facilitating ongoing care and enabling patients to manage their condition effectively. The company focuses on improving treatment outcomes for OCD through its innovative online platform.
GYENNO Technologies
Series B in 2021
GYENNO Technologies is a digital health company developing medical devices for people with disabilities. GYENNO's products include GYENNO spoon, which helps people with hand tremors eat without stress, and the GYENNO matrix, a wearable motion and gait quantitative evaluation system for Parkinson's disease.
Founded in 2013, Oviva specializes in digital behavior change programs for managing type 2 diabetes and obesity. Their platform combines smartphone apps and learning portals, supported by dietitian-led coaching, enabling patients to improve their health remotely and reducing healthcare system costs.
Castor is an international health-tech company that provides a cloud-based clinical data platform designed to streamline the clinical trial process for researchers globally. Founded by CEO Derk Arts, MD, Ph.D., the platform is utilized by over 50,000 researchers in 90 countries, supporting more than 4,000 studies across diverse therapeutic areas, including diabetes, cardiovascular disease, rare diseases, infectious diseases, and oncology. Castor's platform facilitates the collection and analysis of extensive data from both traditional and remote trials, having reached significant milestones such as 180 million data points and 2 million enrolled patients. The company's mission is to make research data reusable, thereby enabling AI-driven clinical trials and enhancing the overall impact of data within the medical research community.
Patient 21
Series B in 2021
Patient21 operates a health platform focused on improving the doctor-patient connection, which they view as essential for effective healthcare. The company aims to modernize the healthcare experience by addressing the fragmented and outdated processes currently prevalent in the industry. By leveraging technology, Patient21 enhances dental clinics with management software that streamlines administrative tasks such as appointment scheduling and patient data management. They also provide electronic health records (EHR) to healthcare professionals, which helps improve diagnostic quality and reduce costs. Through these innovations, Patient21 seeks to facilitate better decision-making for both patients and physicians, ultimately promoting a more personalized and collaborative approach to healthcare.
Know Yourself
Series A in 2021
Know Yourself is a prominent psychology education platform based in China, dedicated to enhancing mental health and well-being among urban youth. With a substantial following of over 3 million on social media, the platform offers a variety of psychoeducational resources, including articles, lectures, and courses. It serves as the largest online community for psychological education in the country, promoting mental health awareness through self-help tools, a supportive community, and a range of psychology-related services. These services cover areas such as self-exploration, developmental psychology, and clinical psychology, aiming to provide valuable insights and support for individuals seeking to understand and improve their mental health.
LenoMed Medical
Series C in 2021
LenoMed Medical is a manufacturer of medical devices focused on improving diabetes management. With over 15 years of research and development experience in infusion technology, the company specializes in creating innovative products such as the InnoTech insulin pump, drug infusion pumps, and related disposables. LenoMed is dedicated to enhancing diabetes care through the integration of continuous glucose monitoring technology with their insulin pumps, aiming to provide patients with better treatment options and monitoring capabilities. Their commitment to advancing diabetes management is reflected in their comprehensive diabetes care management system.
Pediatrix Therapeutics
Series A in 2021
Pediatrix Therapeutics specializes in pediatric pharmaceuticals, focusing on developing and distributing effective, clinically proven children's medicines. Its mission is to provide high-quality, affordable treatment options for Chinese children and families.
Proximie is a health technology company that enables surgeons worldwide to collaborate remotely using augmented reality, artificial intelligence, and machine learning. Its platform allows surgeons to visually guide complex surgeries, democratizing access to advanced surgical knowledge.
B-One Ortho Corp. is a manufacturer of orthopedic healthcare solutions, specializing in artificial joints that facilitate joint replacement surgeries. Founded in 2015 and headquartered in Cedar Knolls, New Jersey, the company also maintains offices in Shanghai and Suzhou, China. Its notable products include the B-One total hip system, which features advanced coating technology and instrumentation, as well as the Juveno bone-conserving femoral prosthesis and primary acetabular systems. These innovations aim to enhance the effectiveness of hip and knee arthroplasty, ultimately helping patients regain their mobility and improve their quality of life.
LakeShore Biopharma
Series B in 2021
Yisheng Biopharma Co., Ltd. is a biopharmaceutical company focused on the research, development, manufacturing, and marketing of immuno-oncology products and vaccines. Founded in 2002 and headquartered in Beijing, the company operates in China, the United States, Cambodia, and Singapore. Yisheng Biopharma utilizes its novel PIKA immunomodulating technology to enhance immune responses against cancers and infectious diseases. Key products under development include YS-ON-001, an investigational therapy aimed at treating advanced solid tumors, as well as YS-HBV-001, a vaccine for hepatitis B, and a PIKA-based rabies vaccine designed for rapid protection against rabies infection. The company's innovative approach targets multiple immune pathways to improve treatment outcomes.
Metcela is a clinical-stage biotechnology company based in Kawasaki, Japan, developing fibroblast-based therapies for heart disease. Its approach uses VCAM-1–positive cardiac fibroblasts derived from a patient’s own heart to repair damaged tissue and reestablish a supportive microenvironment, rather than replacing cells. The lead program, MTC001, aims to restore heart function by promoting natural healing in preclinical studies. Metcela was founded in 2016.
RedPine Medical
Series A in 2020
RedPine Medical, founded in 2015 and headquartered in Guangzhou, China, specializes in the manufacture of single-use medical endoscopes. The company focuses on providing advanced minimally invasive surgical devices for various applications, including urology, gynecology, ear, nose, and throat (ENT), pneumology, gastroenterology, and general surgeries. By emphasizing innovative solutions, RedPine aims to enhance detection, diagnosis, and treatment in medical settings, positioning itself as a global leader in the field of integrated minimally invasive surgical solutions.
Founded in 2016, Owkin is a French-American startup that uses artificial intelligence to enhance medical research. It develops machine learning tools to understand complex biology, identify new treatments, de-risk clinical trials, and develop diagnostics. Owkin's focus is improving drug discovery processes and patient outcomes.
B-One
Venture Round in 2020
B-One Ortho Corp. is a manufacturer of orthopedic healthcare solutions, specializing in artificial joints that facilitate joint replacement surgeries. Founded in 2015 and headquartered in Cedar Knolls, New Jersey, the company also maintains offices in Shanghai and Suzhou, China. Its notable products include the B-One total hip system, which features advanced coating technology and instrumentation, as well as the Juveno bone-conserving femoral prosthesis and primary acetabular systems. These innovations aim to enhance the effectiveness of hip and knee arthroplasty, ultimately helping patients regain their mobility and improve their quality of life.
Founded in 2013, Oviva specializes in digital behavior change programs for managing type 2 diabetes and obesity. Their platform combines smartphone apps and learning portals, supported by dietitian-led coaching, enabling patients to improve their health remotely and reducing healthcare system costs.
Adagene is a clinical-stage biotechnology company focused on developing immuno-oncology antibodies targeting novel epitopes. It employs its proprietary Smart Antibody Technology to enhance success rates, expedite time to market, and reduce development costs for therapeutic antibodies.
Immuneel Therapeutics
Seed Round in 2020
Immuneel Therapeutics specializes in developing innovative cell and gene therapies for cancer treatment. The company focuses on CAR-T cell therapies, which are created by extracting blood cells from patients and genetically engineering healthy immune cells to specifically target malignant cells. This approach allows cancer patients to benefit from advanced cell-based immunotherapies that have the potential to transform their treatment outcomes.
PharmEasy
Series D in 2019
PharmEasy is a health tech startup founded in 2015 by Dharmil Sheth, Mikhil Innani, and Dhaval Shah as a subsidiary of Ascent Health. The company operates an online platform that offers a range of healthcare services, including teleconsultation, medicine deliveries, and diagnostic test sample collections. By digitizing the pharmaceutical supply chain, PharmEasy connects patients with local pharmacies and diagnostic centers, facilitating access to essential medicines and healthcare products. This approach aims to make healthcare services more available, affordable, and accessible to patients.
Founded in 2014, Medbanks specializes in healthcare data processing services. It develops an oncology database by collecting and analyzing clinical information from hospitals.
ekincare is an AI-powered integrated health benefits platform that provides personalized healthcare solutions for organizations and employees. It offers a range of services including online consultations, health check-ups, medicine delivery, wellness programs, and fitness services.
Insilico Medicine
Series B in 2019
Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.
Nanos Medical
Series B in 2019
Nanos Medical specializes in the research, development, manufacturing, and sales of disposable medical devices, primarily targeting the cardiovascular and ear, nose, and throat (ENT) fields. The company offers a range of innovative products, including sinus balloon catheters, eustachian tube balloons, disposable nasopharyngeal airways, nasolacrimal balloons, and drug-eluting stents for sinus applications. Through its advanced medical devices, Nanos Medical aims to enhance treatment options for hospitals and patients, contributing to improved healthcare outcomes.
Founded in 2016, Owkin is a French-American startup that uses artificial intelligence to enhance medical research. It develops machine learning tools to understand complex biology, identify new treatments, de-risk clinical trials, and develop diagnostics. Owkin's focus is improving drug discovery processes and patient outcomes.
TreeENT Health is a specialized healthcare provider focused on ear, nose, and throat (ENT) services, established in 2017 and headquartered in Hangzhou, China. The company operates a chain of medical centers that cater to a variety of ENT conditions, including suppurative otitis media, allergic rhinitis, chronic sinusitis, and thyroid cancer. TreeENT Health utilizes advanced medical technologies, such as minimally invasive surgical techniques, internet-enabled services, and wearable medical devices, to enhance patient care. Their offerings include diagnostic services like Danish ear hearing detection, nasal endoscopy video examinations, and nasopharyngoscopy, along with personalized chronic disease rehabilitation. The integration of online appointment scheduling through platforms like WeChat facilitates convenient access to expert consultations and treatments, ensuring a high-quality experience for patients.
Caplin Point Laboratories
Venture Round in 2019
Caplin Point Laboratories Limited is an India-based pharmaceutical company founded in 1990, specializing in the development, manufacture, and marketing of generic and branded generic formulations. The company offers a diverse range of products, including tablets, capsules, injections (both liquid and lyophilized), ophthalmic solutions, soft gel capsules, ointments, creams, gels, and various specialized formulations such as pre-filled syringes and inhalers. Caplin Point has a strong presence in emerging markets, particularly in Latin America, the Caribbean, and parts of Africa, with over 2000 product licenses globally. The company operates a state-of-the-art manufacturing facility approved by regulatory bodies such as the US FDA and EU-GMP, enabling it to expand into regulated markets for injectables. In addition to its pharmaceutical offerings, Caplin Point also runs an e-commerce platform called QueTenX.
LenoMed Medical
Series B in 2018
LenoMed Medical is a manufacturer of medical devices focused on improving diabetes management. With over 15 years of research and development experience in infusion technology, the company specializes in creating innovative products such as the InnoTech insulin pump, drug infusion pumps, and related disposables. LenoMed is dedicated to enhancing diabetes care through the integration of continuous glucose monitoring technology with their insulin pumps, aiming to provide patients with better treatment options and monitoring capabilities. Their commitment to advancing diabetes management is reflected in their comprehensive diabetes care management system.
Founded in 2014, Medbanks specializes in healthcare data processing services. It develops an oncology database by collecting and analyzing clinical information from hospitals.
B-One Ortho Corp. is a manufacturer of orthopedic healthcare solutions, specializing in artificial joints that facilitate joint replacement surgeries. Founded in 2015 and headquartered in Cedar Knolls, New Jersey, the company also maintains offices in Shanghai and Suzhou, China. Its notable products include the B-One total hip system, which features advanced coating technology and instrumentation, as well as the Juveno bone-conserving femoral prosthesis and primary acetabular systems. These innovations aim to enhance the effectiveness of hip and knee arthroplasty, ultimately helping patients regain their mobility and improve their quality of life.
PharmEasy
Series C in 2018
PharmEasy is a health tech startup founded in 2015 by Dharmil Sheth, Mikhil Innani, and Dhaval Shah as a subsidiary of Ascent Health. The company operates an online platform that offers a range of healthcare services, including teleconsultation, medicine deliveries, and diagnostic test sample collections. By digitizing the pharmaceutical supply chain, PharmEasy connects patients with local pharmacies and diagnostic centers, facilitating access to essential medicines and healthcare products. This approach aims to make healthcare services more available, affordable, and accessible to patients.
WHILL designs and manufactures personal mobility products for indoor and outdoor use, aiming to shift perceptions of mobility devices through advanced technology and thoughtful design. Founded in 2013 and headquartered in San Carlos, California, WHILL develops intelligent personal electric vehicles and mobility solutions that enable mobility-as-a-service, including on-demand fleets and short-term rentals. The company seeks to make public spaces such as airports, hospitals, and vacation destinations more accessible and to empower wheelchair users to lead independent, liberating lives by providing transportation that can be driven on public roads without the need for a driver's license.
Metcela is a clinical-stage biotechnology company based in Kawasaki, Japan, developing fibroblast-based therapies for heart disease. Its approach uses VCAM-1–positive cardiac fibroblasts derived from a patient’s own heart to repair damaged tissue and reestablish a supportive microenvironment, rather than replacing cells. The lead program, MTC001, aims to restore heart function by promoting natural healing in preclinical studies. Metcela was founded in 2016.
Hua Medicine
Series D in 2018
Hua Medicine is a clinical-stage drug development company in China focused on therapies for diabetes and CNS disorders. It develops Dorzagliatin (also known as HMS5552), an oral, first-in-class glucokinase activator for type 2 diabetes, and has advanced Dorzagliatin into NDA-enabling work and Phase III trials in China, including studies in drug-naive and metformin-treated patients. The company is pursuing Dorzagliatin in combination with metformin and in combination with DPP-4 inhibitors, SGLT-2 inhibitors, and insulin in various development stages. In addition, Hua Medicine is developing mGluR5 candidates for Parkinson's disease and related levodopa-induced dyskinesia. The company was founded in 2011 and is headquartered in Shanghai, China.
ekincare is an AI-powered integrated health benefits platform that provides personalized healthcare solutions for organizations and employees. It offers a range of services including online consultations, health check-ups, medicine delivery, wellness programs, and fitness services.
PORT
Venture Round in 2018
Port Inc. is a Tokyo-based company that specializes in various domain-specific vertical media and content marketing tailored to user needs in Japan. Founded in 2011, it operates financial information platforms that facilitate money management through services focused on increasing, borrowing, and saving. Additionally, Port offers a career information platform that connects users with employment opportunities and recruiting companies, enhancing career transition and job matching. The company also provides an online healthcare platform aimed at improving lifestyle habits, supervised by medical professionals, as well as a medical information site addressing lifestyle diseases for individuals and enterprises. Formerly known as Social Recruiting Co., Ltd., Port Inc. rebranded in 2015 to reflect its broader service offerings in internet media and technology across the fields of career, finance, and healthcare.
SDP Japan
Venture Round in 2018
Founded in 2014, SDP Japan operates a platform that facilitates the procurement of medical equipment for bed-based hospitals and clinics. The company specializes in providing surgical materials, pharmaceuticals, and IT system services, aiming to enhance surgical safety and patient care.
B-One
Venture Round in 2018
B-One Ortho Corp. is a manufacturer of orthopedic healthcare solutions, specializing in artificial joints that facilitate joint replacement surgeries. Founded in 2015 and headquartered in Cedar Knolls, New Jersey, the company also maintains offices in Shanghai and Suzhou, China. Its notable products include the B-One total hip system, which features advanced coating technology and instrumentation, as well as the Juveno bone-conserving femoral prosthesis and primary acetabular systems. These innovations aim to enhance the effectiveness of hip and knee arthroplasty, ultimately helping patients regain their mobility and improve their quality of life.
Founded in 2013, Oviva specializes in digital behavior change programs for managing type 2 diabetes and obesity. Their platform combines smartphone apps and learning portals, supported by dietitian-led coaching, enabling patients to improve their health remotely and reducing healthcare system costs.
DoctorLink
Venture Round in 2017
DoctorLink Limited is a health technology company based in London, United Kingdom, founded in 2016. The company offers a range of healthtech products, including online triage, urgent care triage, health risk assessments, and video consultations. DoctorLink aims to enhance the interaction between individuals and their general practitioners (GPs) while alleviating the increasing demand on GP practices. Its services utilize a clinically certified Symptom Assessment tool that integrates with existing practice IT systems to deliver personalized healthcare advice. DoctorLink facilitates appointment bookings with GPs and other NHS services, improving accessibility and efficiency in healthcare delivery. The company is focused on empowering both practices and patients through innovative technology, with plans for future developments, including prescription services and streamlined referrals to various healthcare services.
8fit is a fitness application that aims to transform users' health and wellness journeys by offering personalized solutions. With a user base of over 20 million worldwide, the app provides custom workout plans that can be performed at home without the need for equipment, as well as tailored meal plans. By incorporating tools for weight tracking and progress monitoring, 8fit supports individuals in achieving their unique fitness goals. The company recognizes the challenges people face in their pursuit of health and emphasizes a balanced approach that prioritizes sustainable habits over quick fixes. By fostering an engaging and approachable environment, 8fit helps users navigate their paths to healthier lifestyles.
Haici Technology
Series B in 2017
Haici Technology is a developer of a SaaS-based mobile healthcare service platform aimed at enhancing hospital operations. The company focuses on improving the efficiency of hospital visits, reducing patient wait times, and expanding the range of services offered by healthcare institutions. Its platform integrates online and offline medical services, facilitating better connections between hospitals and patients. By optimizing the patient experience and streamlining administrative workflows, Haici Technology supports hospitals in delivering more effective and efficient healthcare services.
PlasmaGen Biosciences
Venture Round in 2017
PlasmaGen Biosciences Pvt. Ltd., established in 2010 and based in Bengaluru, India, is a biopharmaceutical company specializing in plasma protein therapies. The company manufactures a range of products including PlasmaGlob and AlbuMax, brands of Normal Human Immunoglobulin for Intravenous use, PlasmaRho-D I.V. for Rh immunization suppression, PlasmaRAB for rabies infection prophylaxis, PlasmaHep for hepatitis B exposure, VerBumin for conditions like hypovolemic shock and burns, and Gammafact-VIII. These products cater to various medical fields such as hematology, oncology, immunology, pediatrics, rheumatology, dermatology, and neurology. The company serves clinicians, medical practitioners, corporate hospitals, and government institutions.
Wellframe
Series B in 2017
Wellframe Inc. is a Boston-based company that specializes in digital care management and health advocacy solutions. Founded in 2011, it partners with health plans across the country to enhance the relationship between healthcare providers and members. Wellframe's offerings include a mobile application that facilitates daily health reporting, a care team dashboard to prioritize patient needs, and an array of communication tools for two-way messaging. The company also provides comprehensive operational services, such as implementation support, recruiting, and analytics. Additionally, Wellframe's platform employs real-time data and artificial intelligence to deliver personalized care protocols, enabling caregivers to monitor patient status effectively and identify when intervention is necessary. By focusing on mobile patient engagement and care management, Wellframe aims to improve health outcomes and empower individuals in managing their health.
Health Technology
Venture Round in 2017
Health Technology is a mobile platform for hospitals.
Artemis Health
Series A in 2017
Artemis Health Inc. is a health data analytics company that specializes in providing self-insured employers with a comprehensive platform designed to optimize employee benefit programs. Founded in 2013 and headquartered in Salt Lake City, Utah, the company offers actionable insights into benefit programs, highlighting opportunities and gaps that enable employers to make informed decisions. Its platform allows users to identify issues within their benefits offerings, share insights with relevant stakeholders, and track the effectiveness of implemented solutions. By facilitating data-driven decision-making, Artemis Health helps employers enhance their programs while effectively managing healthcare expenditures and improving overall employee health and wellness coverage.
Medwell Ventures
Series B in 2017
Medwell Ventures is a developer of a healthcare delivery platform designed to enhance accessibility and personalization in medical care. By integrating various delivery channels, the company focuses on providing specialty medical services in the home environment, particularly for chronic diseases outside traditional hospital settings. Utilizing a combination of healthcare expertise, advanced technology, and rigorous processes, Medwell Ventures aims to improve the accuracy and accountability of healthcare, ensuring that patients receive tailored treatments that cater to their specific health needs.
Celes Care
Seed Round in 2017
Celes Care is India's first online health clinic dedicated exclusively to women, based in Hyderabad. The company provides an accessible platform for women to receive healthcare consultations on various topics, including pregnancy care, nutrition, wellness, and general health. Celes Care connects patients with expert female doctors within a minute, ensuring that consultations are not only prompt but also compassionate and tailored to individual needs. By focusing on holistic healthcare, Celes Care aims to empower women with customized guidance in a supportive environment, making quality healthcare more affordable and convenient.
WelbeHealth
Series A in 2017
WelbeHealth serves frail seniors through its PACE (Program of All-Inclusive Care for the Elderly) model, providing comprehensive medical and social care. This enables participants to live better, longer, and more independently. The company coordinates various aspects of care, including medical appointments, therapy sessions, transportation, meals, and personal care services.
Cytek Biosciences
Series B in 2017
Cytek Biosciences, Inc. is a manufacturer and supplier of flow cytometry tools and equipment specifically designed for cancer and cell biology research. The company offers advanced flow cytometers, including the Cytek Aurora and Cytek Northern Lights, as well as the DxP Athena system, which utilizes proprietary technology to enhance the detection of dim populations in a multicolor format. In addition, Cytek provides the QbSure quality control program to ensure the optimal performance of its cytometers and a range of cFluor reagents tailored for use in multicolor applications. Established in 1990 and headquartered in Fremont, California, Cytek has expanded its presence internationally with locations in Bethesda, Maryland; Amsterdam, the Netherlands; Tokyo, Japan; and Shanghai, China. The company was previously known as Cytoville, Inc. before rebranding in August 2015.
Madaket
Venture Round in 2017
Madaket, Inc. is a Cambridge, Massachusetts-based company that specializes in developing SaaS solutions for the healthcare industry. The company focuses on automating the healthcare enrollment process, facilitating connections between healthcare providers and payers to streamline administrative tasks. With a robust platform designed to manage provider data, Madaket enables healthcare organizations to save time and reduce manual errors while effectively tracking enrollment statuses. The company has established exclusive partnerships with notable entities such as TriZetto Provider Solutions and HealthStream, allowing it to support over 300,000 providers and an additional 325,000 providers under contract. Founded in 2012 by Mads Kvalsvik, Scott Soderstrom, Jim Dougherty, Benedict Dsilva, and Ted Achtem, Madaket aims to enhance efficiency in healthcare administration.
Zenflow
Venture Round in 2017
Founded in 2014 by Stanford University Biodesign Fellows collaborating with leading urologists, Zenflow develops a novel spring device to alleviate permanent benign prostatic hyperplasia (BPH) symptoms in men. Its minimally invasive solution preserves natural anatomy and improves patient experience.
Avalyn Pharma
Venture Round in 2017
Avalyn Pharma is a biopharmaceutical company focused on developing therapies for severe respiratory diseases, notably idiopathic pulmonary fibrosis (IPF). Established in 2011, the company is headquartered in Seattle, Washington.
Core Diagnostics
Series B in 2016
Core Diagnostics Private Limited, established in 2012 and located in Gurugram, India, is a clinical laboratory specializing in advanced diagnostic solutions aimed at disease stratification and therapy selection. The company emphasizes the use of next-generation diagnostic techniques to enhance healthcare outcomes, striving to provide comprehensive and high-quality testing services. With a commitment to innovation, Core Diagnostics aims to be a leading provider of sophisticated diagnostic solutions in India, catering to the growing demand for precision medicine.
Eywa Pharma
Venture Round in 2016
Eywa Pharma is a global generic pharmaceutical company established by a team of experienced professionals with a strong background in the pharmaceutical industry. The company focuses on manufacturing a diverse range of generic medications that span various therapeutic areas and dosage forms, including tablets, capsules, and oral suspensions. Through a combination of in-house development and strategic in-licensing, Eywa Pharma aims to ensure continuous access to effective and affordable medicines for patients and healthcare systems.
66nao Brain Training
Venture Round in 2016
66nao offers a cloud-based platform for cognitive rehabilitation, providing digital brain evaluation and training services. Its programs are based on neural network scientific research results.
WHILL designs and manufactures personal mobility products for indoor and outdoor use, aiming to shift perceptions of mobility devices through advanced technology and thoughtful design. Founded in 2013 and headquartered in San Carlos, California, WHILL develops intelligent personal electric vehicles and mobility solutions that enable mobility-as-a-service, including on-demand fleets and short-term rentals. The company seeks to make public spaces such as airports, hospitals, and vacation destinations more accessible and to empower wheelchair users to lead independent, liberating lives by providing transportation that can be driven on public roads without the need for a driver's license.
Hua Medicine
Series C in 2016
Hua Medicine is a clinical-stage drug development company in China focused on therapies for diabetes and CNS disorders. It develops Dorzagliatin (also known as HMS5552), an oral, first-in-class glucokinase activator for type 2 diabetes, and has advanced Dorzagliatin into NDA-enabling work and Phase III trials in China, including studies in drug-naive and metformin-treated patients. The company is pursuing Dorzagliatin in combination with metformin and in combination with DPP-4 inhibitors, SGLT-2 inhibitors, and insulin in various development stages. In addition, Hua Medicine is developing mGluR5 candidates for Parkinson's disease and related levodopa-induced dyskinesia. The company was founded in 2011 and is headquartered in Shanghai, China.
Cytek Biosciences
Venture Round in 2016
Cytek Biosciences, Inc. is a manufacturer and supplier of flow cytometry tools and equipment specifically designed for cancer and cell biology research. The company offers advanced flow cytometers, including the Cytek Aurora and Cytek Northern Lights, as well as the DxP Athena system, which utilizes proprietary technology to enhance the detection of dim populations in a multicolor format. In addition, Cytek provides the QbSure quality control program to ensure the optimal performance of its cytometers and a range of cFluor reagents tailored for use in multicolor applications. Established in 1990 and headquartered in Fremont, California, Cytek has expanded its presence internationally with locations in Bethesda, Maryland; Amsterdam, the Netherlands; Tokyo, Japan; and Shanghai, China. The company was previously known as Cytoville, Inc. before rebranding in August 2015.
Oviva
Venture Round in 2016
Founded in 2013, Oviva specializes in digital behavior change programs for managing type 2 diabetes and obesity. Their platform combines smartphone apps and learning portals, supported by dietitian-led coaching, enabling patients to improve their health remotely and reducing healthcare system costs.
PORT
Venture Round in 2016
Port Inc. is a Tokyo-based company that specializes in various domain-specific vertical media and content marketing tailored to user needs in Japan. Founded in 2011, it operates financial information platforms that facilitate money management through services focused on increasing, borrowing, and saving. Additionally, Port offers a career information platform that connects users with employment opportunities and recruiting companies, enhancing career transition and job matching. The company also provides an online healthcare platform aimed at improving lifestyle habits, supervised by medical professionals, as well as a medical information site addressing lifestyle diseases for individuals and enterprises. Formerly known as Social Recruiting Co., Ltd., Port Inc. rebranded in 2015 to reflect its broader service offerings in internet media and technology across the fields of career, finance, and healthcare.
Cipla Health
Venture Round in 2016
Cipla Health is a pharmaceutical company dedicated to developing and commercializing consumer healthcare products. It specializes in creating over-the-counter medicines, including nicotine replacement therapy gum, cough lozenges, immunity booster supplements, and pregnancy care medicines. By focusing on these areas, Cipla Health aims to enhance the healthcare experience for patients and consumers alike. Its commitment to providing accessible and effective healthcare solutions underscores its role in the wellness sector.
Adagene is a clinical-stage biotechnology company focused on developing immuno-oncology antibodies targeting novel epitopes. It employs its proprietary Smart Antibody Technology to enhance success rates, expedite time to market, and reduce development costs for therapeutic antibodies.
PatientPing
Series A in 2015
PatientPing, Inc. is a health technology company that has developed a national care coordination network aimed at enhancing communication among healthcare providers. Founded in 2013 and headquartered in Boston, Massachusetts, the company offers real-time notifications and care guidelines to various healthcare professionals, including physicians, nurses, case managers, and care coordinators. This network spans hospitals, emergency departments, accountable care organizations, physician practices, skilled nursing facilities, home health agencies, and payers. PatientPing's platform includes a tool called Spotlights, which leverages real-time data to analyze utilization and performance trends in patient care. By improving information sharing among care teams, PatientPing facilitates higher quality, cost-effective care, ultimately aiming to enhance patient outcomes and experiences. The company also maintains a strategic partnership with MedAllies, Inc. and operates as a subsidiary of SVB Leerink Holdings LLC.
Celon Laboratories
Venture Round in 2015
Founded in 2001, Celon Laboratories is a Hyderabad-based pharmaceutical company specializing in the development, manufacturing, and marketing of niche therapy products. Its portfolio includes oncology and critical care products, available in various dosage forms, serving markets across Asia Pacific, Africa, Latin America, CIS countries, and Eastern Europe.
Medwell Ventures
Series A in 2015
Medwell Ventures is a developer of a healthcare delivery platform designed to enhance accessibility and personalization in medical care. By integrating various delivery channels, the company focuses on providing specialty medical services in the home environment, particularly for chronic diseases outside traditional hospital settings. Utilizing a combination of healthcare expertise, advanced technology, and rigorous processes, Medwell Ventures aims to improve the accuracy and accountability of healthcare, ensuring that patients receive tailored treatments that cater to their specific health needs.
VitalWare
Series A in 2015
VitalWare, LLC is a provider of revenue cycle software-as-a-service (SaaS) solutions tailored for healthcare organizations. Established in 2011 and based in Yakima, Washington, the company offers a comprehensive suite of products designed to enhance efficiency in documentation, coding, billing, and auditing processes. Key offerings include VitalCDM, which streamlines hospital chargemaster management; VitalCDI, a tool that enhances clinical documentation; and VitalIntelligence, which assists with regulatory compliance. Additionally, VitalWare provides professional services that support healthcare providers in coding guidance, process improvement, and financial impact analysis. With a client base of over 590 healthcare institutions, VitalWare aims to help its partners achieve optimal reimbursement and maintain a healthier revenue cycle through innovative cloud-based technologies and expert regulatory content.
Gu Sheng Tang
Venture Round in 2015
Gu Sheng Tang (GST) is a China-based healthcare services provider that operates a chain of private clinics specializing in traditional Chinese medicine.